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LETTER TO THE EDITOR
Characterization of SHOX Deletions
in Le´ri-Weill Dyschondrosteosis (LWD) Reveals
Genetic Heterogeneity and No
Recombination Hotspots
To the Editor: In the July 2005 and March 2006 issues of
the Journal, Schneider et al.1 and Zinn et al.,2 respectively,
reported mapping studies of SHOX (MIM 312865) dele-
tions in patients with Le´ri-Weill dyschondrosteosis (LWD
[MIM 127300]). In their study, Schneider et al.1 reported
that the majority (73%) of patients with LWD who had
SHOX deletions shared a 3′ deletion breakpoint hotspot
located downstream of SHOX. Zinn et al.2 identified a dif-
ferent 3′ breakpoint hotspot located several hundred ki-
lobases farther downstream in 86% of Hispanic patients,
whereas the recombination hotspot described by Schnei-
der et al.1 was not observed.
We characterized the SHOX deletion limits in a cohort
of 48 European patients with LWD ( ) and Langernp 47
mesomelic dysplasia (LMD [MIM 249700]) ( ). SHOXnp 1
deletions were originally detected by multiplex ligation
probe amplification (MLPA) (MRC Holland) or microsatel-
lite analysis (DXYS10092, DXYS201, DYS290, DXYS10093,
DXYS233, and DXYS234) and subsequently were finely
mapped using a dense panel of microsatellites and SNPs.3
Four newly identified microsatellites (Tandem Repeat
Finder), located 133, 54, 31, and 19 kb 5′ of SHOX (table
1), and 59 SNPs, 12 of which were previously unreported
(table 2), were analyzed.
In our study, the SHOX-encompassing deletions were
highly heterogeneous for both extension and breakpoint
localization, with no recombination hotspot observed (fig.
1). Deletion extensions varied from at least 8 kb to 38 Mb.
The majority of deletions (45 of 49) encompassed the en-
tire SHOX gene, whereas 4 were partial deletions (deletions
1–4) (fig. 1). The smallest deletion (in proband 3) included
exons 4–6a (8–21 kb) and was detected only by MLPA5
(fig. 1). In seven probands (14%), deletions extended into
the Xp-specific region (figs. 1 and 2). The majority (61%)
of deletions were interstitial, whereas the remaining 39%
encompassed all analyzed telomeric markers, thus possi-
bly extending to the telomere. Because of the lower mi-
crosatellite density in the telomeric pseudoautosomal re-
gion 1 (PAR1), the 5′ breakpoints of 16 subjects were re-
evaluated using the commercial SHOX MLPA kit com-
plemented with seven additional synthetic MLPA probes
(table 3 and fig. 3). Only three patients—29, 30, and 31—
possibly share a 3′ breakpoint between DXYS10082 and
DXYS10084, and only probands 35 and 36 possibly share
the same 5′ and 3′ breakpoint.
The results from this study are in contrast to previous
reports of the presence of 3′ deletion breakpoint hotspots
in patients with LWD.1,2 Schneider et al.1 reported a com-
mon proximal breakpoint in 20 of 27 patients with LWD.
In a subset of six patients with LWD, this common break-
point was refined to an ∼5-kb interval 666–671 kb from
Xpter, corresponding to a point between DXYS10083 and
S14. In contrast, no breakpoint hotspots were observed in
our study; moreover, none of our 48 subjects had a break-
point within this interval. This discrepancy is unlikely to
be explained by population differences between studies,
since all subjects were of European origin. The presence
of multiple 5′ breakpoints in both studies also excludes
the possibility of a founder effect. Differences in the meth-
odology used for deletion mapping may explain the dis-
crepancy between the studies. Whereas Schneider et al.1
initially used microsatellites to identify the deletion limits,
subsequent mapping was performed by FISH. They ana-
lyzed a number of PAR1 cosmids, by “walking” away from
SHOX until they identified a probe that gave two hybrid-
ization signals. In 20 subjects, the first nondeleted probe
downstream of SHOX was cosmid P0117. No additional
probes downstream of P0117 were reported in these 20
subjects. The deletion breakpoint was defined by cosmids
29B11 distally and P0117 proximally. Further mapping of
the breakpoint region was achieved by SNP analysis in 6
of these 20 subjects. A breakpoint hotspot was observed
within a 5-kb interval. These findings were then extrapo-
lated to all 20 subjects with a common breakpoint de-
tected by FISH. In our opinion, this inference must be
taken with care because of the observation reported else-
where that PAR1 is enriched for repetitive elements and
duplications6 and the fact that marker P117, located
within cosmid P0117, was mapped to multiple Xp loca-
tions.7 Thus, if the cosmid P0117 is misassigned or com-
prises repetitive sequences, two FISH signals may be ob-
served. This may be misleading, since the presence of the
deletion would be masked.
In our study, we employed MLPA and segregation anal-
ysis of a large number of microsatellites and SNPs for pro-
bands with LWD and their parents. The deletions carried
by 42 of 48 patients extended beyond the breakpoint re-
ported by Schneider et al.1 The large number of polymor-
phic markers analyzed excludes the possibility of allele
dropout and nonpaternity. To investigate the discrepancy
between our study and that of Schneider et al.,1 we tested
a subset of subjects with use of FISH. As expected, all four
tested subjects had deletion of cosmid 29B11. We also
attempted to analyze cosmid P0117 (a kind gift from Dr.
G.-J. van Ommen), but we could not obtain hybridization
signals for any of the four subjects. However, none of the
cases were deleted for a series of fosmids, which mapped
to the same region (613–747 kb) (information available
from the authors). Furthermore, no deletion breakpoint
hotspots were identified in patients with LWD who had
PAR1 deletions located downstream of SHOX5 or among
the three largest studies of patients with Xp deletions.8–11
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Table 1. Novel Microsatellite Markers
Markera
Oligonucleotide
(5′r3′)
Size
Range
(bp) HeterozygositySense Antisense
DXYS10136 CTGAACTCAGAATCGGGACC CCCAGGAGCCCAGGAGATTGA 303–323 .85
DXYS10137 CCCAGGCCCTGTTTACGCTTCG TATCCTCACAACTGCGTCTTCC 180–210 .90
DXYS10138 GTACATAGATGGCAGATAGATG CTGCATGTATACACACTGTAAT 197–221 .73
DXYS10139 AGCCCCAACCCTCCATGATACTGA GCAAAGGCATCTGTTTAAGTAACG 131–203 .24
NOTE.—PCR conditions for the amplification of microsatellites DXYS10136, DXYS10137, DXYS10138, and
DXYS10139 were as follows: 1# Qiagen Hotstart Taq buffer, 0.5 units of Hotstart Taq polymerase, 2.0 mM
MgCl2, 200 mM dNTPs (50 mM each), and 400 nM of each primer. Cycling conditions for DXYS10137,
DXYS10138, and DXYS10139 were as follows: initial denaturation at 94C for 15 min; 35 cycles for 30 s at
94C; 30 s at 49C, 58C, and 55C, respectively; and 40 s at 72C, with a final extension for 8 min at 72C.
For the amplification of DXYS10136, we used a touchdown protocol for easier allele calling. Cycling conditions
were as follows: initial denaturation at 94C for 15 min, 16 cycles for 30 s at 94C, 30 s at 58C–66C ramp
(0.5C per cycle), and 40 s at 72C, followed by 16 cycles for 30 s at 94C, 30 s at 58C, and 40 s at 72C.
The program terminated with a final extension for 8 min at 72C.
a Further details can be found at the GDB Human Genome Database.
Table 2. Oligonucleotide Sequences and PCR Conditions of the PAR1 Amplicons That Contain the 18
Analyzed SNPs
dbSNP ID
Our
Amplicon
ID SNP
Oligonucleotide
(5′r3′)
Annealing
Temperature
(C)
Amplicon
Size
(bp)Sense Antisense
rs5988284 S27 G/A GTCATGGCCGGATCCT ACTTGTTACCACGAGCCCG 52 422
rs6644380 G/A
rs5946512 G/A
rs17148729 S21 A/C GGATTCCTGGTGGTTGCTAT GCAGTAATCACATTAGGGTAAATAA 55 997
ss49845888 G/A
ss49845889 T/A
ss49845890 S22 C/T TGGGGACAAATTATTCATTGGATTC CTTGACCTTGTGATCTGCCCTCTTC 55 986
ss49845891 G/A
ss49845892 G/A
ss49845893 T/C
ss49845894 G/A
ss49845895 S23 T/C CCACCACCATGCCTAGCTGA ATGAGAGACAGGTTTCCACTGT 55 377
ss49845896 S25 C/T CTCCCCATTGCGGTTGCACGAATTT CCGTATGCACAATTCATGGGCG 56 1,182
rs6644384 A/G
rs6644385 C/T
ss49845885 S20 T/C CAATACCAATCTTGCTTCAACCCAC GGGATCAACAGACACTAATACGCA 55 720
ss49845886 G/A
ss49845887 C/T
NOTE.—The 12 previously unreported SNPs are shown in bold.
In the second recent study of SHOX deletion mapping
of probands with LWD, Zinn et al.2 employed molecular
methods to analyze 30 LWD-affected families with SHOX
deletions. In 17 of 26 informative cases, the deletion in-
cluded the DXYS233 marker—that is, extended beyond
the 666–671 kb interval defined by Schneider et al.1 De-
tailed STS mapping was performed on a subset of 11 sub-
jects for whom human-hamster hybrids were constructed.
This revealed a second hotspot in 8 of the 11 subjects,
between 1.18 and 1.42 Mb, in a region that still contains
a number of gaps in the human PAR1 sequence. In con-
trast to the results of Zinn et al.,2 only three of our subjects
had a 3′ breakpoint within this region. However, a founder
effect could not be excluded in their study, since five of
the six probands also shared 5′ breakpoints.
Although the underlying molecular mechanism remains
to be elucidated, nonhomologous end joining may ex-
plain the occurrence of the scattered deletion breakpoints
observed in the present study. The architectural features
of the PAR1 deletion–flanking sequences include a high
incidence of Alu and long interspersed nucleotide elements
(LINE),12 which has resulted in a recombination fraction
∼20-fold higher per unit of physical distance for the whole
PAR1 than for the genome-average rate of 1 cM per Mb.13
Furthermore, even within different segments of the PAR1,
the recombination fraction seems to be variable, with a
range from a 13–23-fold greater increase at the telomere
to a 26–38-fold increase near the pseudoautosomal bound-
ary.14 Thus, one can expect—and, indeed, observe—the
recurrent incidence of deletions in this region in LWD.
An important diagnostic point was the observation that
a significant proportion of probands (14% [7 of 48]) were
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Figure 1. Characterization of PAR1 deletions in 47 patients with LWD and 1 patient with LMD, through use of a panel of microsatellites
and SNPs (not to scale). Blackened areas indicate the presence of two copies of the marker or SNP, unblackened areas indicate the
presence of a deletion, and shaded areas indicate the noninformative areas where the breakpoints are located. Distances are according
to Ensembl Genome Browser coordinates; markers DXYS10136–DXYS234 are stated in kilobases, whereas markers DXYS10097–DXS1068
are stated in megabases. Deletion sizes are in kilobases unless otherwise stated. Proband 10 (indicated by an asterisk [*]), the subject
with LMD, has been reported elsewhere; the proband inherited a familial deletion from her mother (10M), and a de novo deletion of
the paternal allele (10P) was also included in the cohort.4 AFM248th5 is an STS marker.
Table 3. Novel Synthetic MLPA Probes Incorporated into the MRC Holland SHOX Kit
Nomenclature
Approximate Distance
from Telomere
(kb) Sequence at Ligation Site
Probe 1 (GTPBP6 exon 2) 169 AAGATCAGGAAGGCCTTGGACAGG-CTTCGCAAGAAGAGGCACCTGCTC
Probe 2 (PPP2R3B exon 2) 292 CGCAGGACTCCGTCAACGTGGATG-CCGTCATCAGCAAGATCGAGAGCA
Probe 3 350 AGCCAGCATCCGTGGTCTCTCTAT-AGTGGCCTCACGGTCTCCAGCCAG
Probe 4 390 TCATCTTGTCTCAGAGACCTCGGA-GAGCTCCCAGAGCCTGGCTGCCAC
Probe 5 430 GGTGCTCAGAGCCTCTAGGAGGAT-CCTTTCGGAAAGCAAGTCTGCTGT
Probe 6 470 TCAGGGCCCAAGCCAGCGGAAGCG-CTGCGCTCACTAAAGACGCTCCGT
Probe 7 510 ATGCTGGCAATATGG CGGTCACCA-ATAGTGTTCATCAACTCCAGAGGG
found to carry PAR1 deletions that extended into the X-
specific region of Xp22.3-Xp21.2 (fig. 2). Male offspring
of these females would have a 50% chance of inheriting
the Xp terminal deletion and therefore could be either
inviable or at risk of presenting with severe clinical com-
plications. In the LWD/idiopathic short stature (ISS) co-
hort studied by Schneider et al.,1 3 of 27 subjects with
LWD and 1 of 6 subjects with ISS also presented with
deletions of the entire analyzed PAR1 and with the likely
extension into the Xp22.3 region, although the deletion
limits were not available.
In conclusion, we detected a high level of genetic het-
erogeneity of SHOX deletions in a European cohort of 48
patients with LWD/LMD who have a significant propor-
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Figure 2. Detailed schematic representation of the 3′ deletion limits of probands 10P and 43–48, which extend beyond the PAR1 into
X-specific regions. These samples correspond to one male (proband 43), five sporadic females (44, 45, 10P, 47, and 48), and proband
46, a familial case from a family in which only affected females were observed. Blackened areas indicate the presence of two copies
of the marker or SNP, unblackened areas indicate the presence of a deletion, and shaded areas indicate the noninformative areas where
the breakpoints are located. Localization of the microsatellite markers and the genes located within the deletions are indicated by
vertical lines above and below the line, respectively.
tion of deletions extending beyond the PAR1 boundary.
Until recently, molecular analysis of patients with LWD
included only the screening of SHOX deletions and inser-
tions, deletions, and point mutations within SHOX. Our
recent findings3 and those reported here emphasize the
necessity of improving the molecular diagnosis given to
LWD-, LMD-, and ISS-affected families by means of in-
cluding deletion screening of the PAR1 region downstream
of SHOX and, in certain cases, of analyzing whether the
3′ boundaries extend into the Xp22.3 region.
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follows:
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/ (for SNP identifi-
cation numbers [listed in table 2], including the new accession
numbers ss49845885, ss49845886, ss49845887, ss49845888, ss-
49845889, ss49845890, ss49845891, ss49845892, ss49845893,
ss49845894, ss49845895, and ss49845896)
Ensembl Genome Browser, http://www.ensembl.org/ (for sequence
information of the human X and Y chromosomes)
GDB Human Genome Database, http://www.gdb.org (for
further details about the new microsatellites DXYS10136,
DXYS10137, DXYS10138, and DXYS10139)
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for SHOX, LWD, and LMD)
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